Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial ion transporters are a diverse group of membrane proteins responsible for the translocation of ions (such as Na⁺, K⁺, Ca²⁺, Cl⁻, Fe²⁺, Zn²⁺, Mn²⁺, and others) across bacterial cell membranes. They are essential for maintaining ion homeostasis, pH balance, membrane potential, and the transport of nutrients and waste products. This transporter superfamily includes a wide variety of protein families, such as ATP-binding cassette (ABC) transporters, secondary active transporters (e.g., cation/proton antiporters), P-type ATPases, and specialized efflux pumps involved in antibiotic resistance. These proteins act by mechanisms such as active transport (coupled to ATP hydrolysis or ion gradients) or facilitated diffusion. Bacterial ion transporters are considered promising (and validated) therapeutic targets, as their inhibition can disrupt bacterial survival, impair resistance mechanisms (notably multidrug efflux pumps), and sensitize bacteria to antibiotics. However, 'bacterial ion transporter' is not a single molecule but encompasses hundreds of distinct protein families with varying structures and specificities. For structured data purposes, this term is best replaced by the specific family or protein of interest (e.g., "Bacterial cation diffusion facilitator," "Multidrug efflux transporter AcrB," etc.). Notes: - 'Bacterial ion transporters' is a **category** or superfamily, not a unique molecule or gene, making this a problematic or 'incorrect' entry when a specific individual target is required, but broadly appropriate when discussing transporter-targeting therapies. - For database structuring, listing families (e.g., RND transporters, MFS transporters, ABC transporters, CDF family, etc.) is recommended for specificity. **Key point**: 'Bacterial ion transporters' refers to a very broad group of proteins and not to a single, well-defined molecular target, so it is 'incorrect' by the naming conventions requested for strict uniqueness and specificity.
Inhibition of ion transport (blocking specific transporter families) Efflux pump inhibition (prevents removal of antibiotics) Augmentation of antibiotic entry (via increased membrane permeability) Direct disruption of membrane potential and homeostasis
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ion transporter.